Hypokalemia in Emergency Medicine is an article that discusses potassium levels in the body and defines hypokalemia as a potassium level below 3.5 mEq/L. It notes that nearly 98% of the body's potassium is intracellular and plays an important role in cellular membrane potential. Hypokalemia can result from renal or GI losses, inadequate diet, medications, or a transcellular shift of potassium into cells. As many as 20% of hospitalized patients and 14% of outpatients undergoing testing may have mild hypokalemia, though it is clinically significant in only 4-5% of cases. Approximately 80% of patients on diuretics become hypokalemic.
El 17 de octubre de 2014, la Fundación Ramón Areces celebró una nueva conferencia del ciclo 'Envejecimiento, Sociedad y Salud: envejecimiento y enfermedad', que organiza en colaboración con el Centro de Estudios del Envejecimiento. En esta ocasión, el doctor Valentín Fuster, director del Centro Nacional de Investigaciones Cardiovasculares Carlos III- CNIC, habló sobre 'Enfermedad subclínica de corazón y cerebro: el reto de la década'. En esta entrevista previa a su intervención, deja claro que nunca es tarde para cuidarse y que la clave no está tanto en el corazón, sino en el cerebro, donde se toman las decisiones para llevar hábitos de vida saludables.
We conducted a retrospective study of 178 community dwelling elderly on anemia which was defined as hemoglobin < 13 gm/ dl in males and < 12 gm/dl in females (WHO guidelines).
Methods: This was a retrospective chart review of patients aged ≥ 95 years, who were seen over a two year period at the University of Arkansas for Medical Sciences.
Background: In a previous study, we demonstrated that swine supplemented with alcohol had improved insulin signaling in the heart. However, the effect of alcohol on insulin signaling in the setting of metabolic syndrome in the heart remains unknown. We developed a follow-up study to evaluate the effects of alcohol on ischemic myocardium in animals with metabolic syndrome.
El 17 de octubre de 2014, la Fundación Ramón Areces celebró una nueva conferencia del ciclo 'Envejecimiento, Sociedad y Salud: envejecimiento y enfermedad', que organiza en colaboración con el Centro de Estudios del Envejecimiento. En esta ocasión, el doctor Valentín Fuster, director del Centro Nacional de Investigaciones Cardiovasculares Carlos III- CNIC, habló sobre 'Enfermedad subclínica de corazón y cerebro: el reto de la década'. En esta entrevista previa a su intervención, deja claro que nunca es tarde para cuidarse y que la clave no está tanto en el corazón, sino en el cerebro, donde se toman las decisiones para llevar hábitos de vida saludables.
We conducted a retrospective study of 178 community dwelling elderly on anemia which was defined as hemoglobin < 13 gm/ dl in males and < 12 gm/dl in females (WHO guidelines).
Methods: This was a retrospective chart review of patients aged ≥ 95 years, who were seen over a two year period at the University of Arkansas for Medical Sciences.
Background: In a previous study, we demonstrated that swine supplemented with alcohol had improved insulin signaling in the heart. However, the effect of alcohol on insulin signaling in the setting of metabolic syndrome in the heart remains unknown. We developed a follow-up study to evaluate the effects of alcohol on ischemic myocardium in animals with metabolic syndrome.
Iron Deficiency : An Overlooked Aspect of Heart Failure Managementmagdy elmasry
Iron deficiency: a comorbidity that goes unnoticed in heart failure.Optimization of heart failure treatment.
Types of iron deficiency.Absolute ID &Functional ID.Iron Deficiency in Heart Failure :
A Therapeutic Target
Iron therapy for the treatment of iron deficiency
in chronic heart failure: intravenous or oral?
Intensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular DiseaseAdvancingDialysis.org
Cardiovascular-related deaths in prevalent dialysis patients are common.
The long interdialytic interval, commonly referred to as the 2-day “Killer Gap,” is a time of heightened risk of mortality and morbidity with conventional hemodialysis. Multiple randomized clinical trials show intensive hemodialysis significantly reduces left ventricular mass and more frequent hemodialysis has associated with lower risk of cardiovascular-related hospitalizations.
Hurdles and new players in the management of chronic heart failure with reduc...Dhritisdiary
Watch the slideshow for a better understanding: https://youtu.be/CsXvS1hA330
1. Learn the standard therapy in HFrEF
2. Learn its challenges
3. Learn the new drugs for HFrEF.
Iron Deficiency : An Overlooked Aspect of Heart Failure Managementmagdy elmasry
Iron deficiency: a comorbidity that goes unnoticed in heart failure.Optimization of heart failure treatment.
Types of iron deficiency.Absolute ID &Functional ID.Iron Deficiency in Heart Failure :
A Therapeutic Target
Iron therapy for the treatment of iron deficiency
in chronic heart failure: intravenous or oral?
Intensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular DiseaseAdvancingDialysis.org
Cardiovascular-related deaths in prevalent dialysis patients are common.
The long interdialytic interval, commonly referred to as the 2-day “Killer Gap,” is a time of heightened risk of mortality and morbidity with conventional hemodialysis. Multiple randomized clinical trials show intensive hemodialysis significantly reduces left ventricular mass and more frequent hemodialysis has associated with lower risk of cardiovascular-related hospitalizations.
Hurdles and new players in the management of chronic heart failure with reduc...Dhritisdiary
Watch the slideshow for a better understanding: https://youtu.be/CsXvS1hA330
1. Learn the standard therapy in HFrEF
2. Learn its challenges
3. Learn the new drugs for HFrEF.
Debra K. Katzman, MD ABSTRACT The purpose of the current article .docxedwardmarivel
Debra K. Katzman, MD* ABSTRACT The purpose of the current article is to summarize the evidence-based medical complications and treatments that are both common and unique to adolescents with anorexia nervosa (AN). Recent literature relating to the cardiovascular complications,refeedingsyndrome, alterations in linear growth, impaired bone mineralaccretion,and structuralandfunctional brain changes was reviewed. The literature suggests that the medical complications in adolescents with AN are different from those reported in adults. The unique clinical presentation, the early onset, and the unknown impact of these
complications underscore the need for early identification and treatment of AN in adolescents. AN is a serious disorder with significant and often life-threatening medical complications. The increasing growth of evidence highlights the importance of early identification and treatment by an interdisciplinary team of health care providers who have expertise in managing adolescents with AN and their medical sequelae. ª 2005 by Wiley Periodicals, Inc.
Keywords: medical complications; adolescents; anorexia nervosa
(Int J Eat Disord 2005; 37:S52–S59
Introduction
Anorexia nervosa (AN) in adolescents can cause significant medical complications in every organ system in the growing and developing body.1 Critical to the ongoing advancement of our understanding of AN in adolescents is the steady growth of evidence on the identification and management of the multitude of medical complications. Although many of these medical complications improve with nutritional rehabilitation and recovery from the eating disorder, some are potentially irreversible. As such, the long-term implications of these medical complications that typically begin in the formative years of adolescence are unknown. The current article summarizes the evidence-based literature on common medical complications that have been specifically studied in adolescent populations with AN over the past 20 years. We will focus on the cardiovascular and metabolic complications with a particular emphasis on refeeding syndrome, alterations in linear growth, impaired bone mineral accretion, and reference to structural and functional brain
changes, all of which have been studied in adolescents with AN.
Cardiovascular Complications
AN is a life-threatening condition, with significant risk of death due to cardiac complications. One third of the deaths in adults with eating disorders are due to cardiac complications.2 There are no such data regarding adolescents with AN. Cardiac involvement is present in the early stages of the disorder in adolescents with AN.3,4 In fact, even with a short duration of illness, there are both functional and structural cardiac abnormalities that appear to be reversible with early identification and treatment.3 Upon reviewing the adolescent eating disorder literature, the most common reported cardiovascular complications include electrocardiographic abnormalities such as.
Join Doc Andrew to see the research that supports plant based diet recommendations. Address common misconceptions. Ask questions @DenverWWAD or join current discussions at #PlantBased, #PlantBasedRx, or #CulinaryRx.
Also, enjoy bonus learning with these topic-related, 2-minute podcasts by Dr. Andrew:
"The Plant Based Diet and How to Get Started"
https://soundcloud.com/denverwwad/healthcast-23
"Eat Your Way to the Finish Line"
https://soundcloud.com/denverwwad/healthcast-4
Andrew Freeman, MD, FACC, FACP is a cardiologist and Assistant Professor of Medicine at National Jewish Health, Denver, Colorado. He is part of the leadership of both the local and national American College of Cardiology.
Dr. Freeman founded the Denver chapter of the Walk with a Doc program and is the leader of Walk with a Doc-Colorado.
Walk with a Doc-Denver is a free health improvement and community empowerment initiative. Local doctors and a team of healthcare professionals--all volunteers--host Saturday walks that include expert talks, health screenings, refreshments, and motivational giveaways. For more info visit: Denver.WalkWithADoc.org
Hypokalemic Periodic Paralysis A Case Reportijtsrd
"Hypokalemic periodic paralysis HPP is a medical emergency with prevalence of 1 in 100,000 . Rapid management is very important since, very low potassium levels can lead to cardiac complications . In this case, a twenty four year old female without a similar history in the family, having hypokalemia periodic paralysis attack is presented. This case report study has been presented for the consideration of the rare HPP in patients presenting with sudden muscle weakness. Blessy Rachal Boban | Cillamol K. J | Elena Cheruvil | Sheffin Thomas | Tony Abraham ""Hypokalemic Periodic Paralysis: A Case Report"" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-3 , April 2019, URL: https://www.ijtsrd.com/papers/ijtsrd21658.pdf
Paper URL: https://www.ijtsrd.com/pharmacy/pharmacy-practice/21658/hypokalemic-periodic-paralysis-a-case-report/blessy-rachal-boban"
A slide series to learn and appreciate the importance and the potential of Personalized/Individualized Genomic Medicine. It briefly goes through the idea of biotechnology and the advancements we have made in biology and technology. A series of applications for genomic medicine is then explored, not failing to mention the challenges we have to overcome as well, for the next medical revolution.
A case for personalized medicine is presented.
Running head CASE STUDY 2 13CASE STUDY .docxsusanschei
Running head: CASE STUDY 2 1
3
CASE STUDY 2
Congestive Heart Failure
Case Study 2
This case study is about Mr. P, a 76 year old male, hospitalized usually to treat cardiomyopathy and congestive heart failure (CHF). The author describes the approach to care, treatment plan, method to provide education and a teaching plan about the CHF. Congestive heart failure is defined as “the state in which the heart is unable to pump blood at a rate adequate for satisfying the requirements of the tissues with function parameters remaining within normal limits usually accompanied by effort intolerance, fluid retention, and reduced longevity” (Denolin, 1983, p. 445).
Approach to care
· Assessment of patient: Physical examination of the patient (at each visit), with particular attention to assessment of their vital signs, cardiovascular system (including volume status), signs of deterioration and co-morbid conditions.
· Assessment and management of the patient’s cardiovascular risk factors (e.g. hypertension, dyslipidaemia, diabetes, smoking and obesity).
· Assessment of the patient’s nutritional status.
· Assessment of the patient’s potential for adverse effects of medicines
· Regular reassessment of the patient’s biochemistry (including urea and creatinine) and haematology (including haemoglobin) parameters.
· Assessment of the patient’s daily fluid and salt intake from food and drink.
· Ongoing monitoring of the patient’s electrolytes (particularly serum sodium and potassium levels) and renal function.
· Monitor intake and output strictly and take daily weight.
Treatment Plan
CHF is a complex clinical syndrome; therefore, treatment plan includes the focus on the fundamental causes. Appropriate combination of medicines, control over lifestyle with careful monitoring is the basic treatment for CHF.
· An Angiotensin-Converting Enzyme (ACE) inhibitor (captopril, enalapril etc) or an Angiotensin II receptor blocker (ARB) helps to relax the blood vessels and enhance the blood flow.
· Beta-blockers (bisoprolol, carvedilol etc) reduce the blood pressure and stabilize the heart beat rate.
· Diuretics (lasix, bumex etc) remove more sodium and water from the body, which helps in lowering blood pressure. Also, spironolactone and eplerenone called as potassium-sparing diuretics help to retain potassium.
· Other drugs include anticoagulant, statin and digoxin as per doctor’s recommendation.
Besides medication and diet alteration, devices and surgical procedures are available for the treatment of heart failure. An implantable cardiac defibrillator (ICD), coronary artery repair and valve repair or replacement (as appropriate) can be done (Heart.org, 2016).
Education method
Heart failure patients and their family members should acquire the education, problem solving abilities and motivation regarding the treatment plan, medications and effective participation in self-care. “Patient education and post discharge management have demonstrated be ...
Presented November, 3 2017.
Peter McCullough, MD, MPH, FACC, FACP, FCCP, FAHA, FNKF
Baylor University Medical Center
EMERGING PRESCRIPTION PROTOCOL FOR MORE FREQUENT HEMODIALYSIS
Ultrafiltration controlled prescription guide that improves treatment tolerability, reduces dialysis-induced cardiomyopathy, addresses chronic fluid overload while meeting clinical targets.
Discussion lead:
Allan Collins, MD, FACP
University of Minnesota School of Medicine
Chief Medical Officer, NxStage Medical, Inc.
CURBSIDE CONSULTATION: HOME DIALYSIS PATIENT CONSIDERATIONS
Biochemical, health-related quality of life, and economic factors when transitioning patients home.
Discussion lead:
Paul Komenda, MD, MHA, FRCPC
Seven Oaks General Hospital
REAL LIFE EXPERIENCE: PHYSICIAN AND PATIENT LEARNINGS
Dr. Kraus will discuss the prescribed regimen while Mr. Davis shares his clinical and lifestyle experiences as a more frequent hemodialysis patient.
Discussion leads:
Michael Kraus, MD, FACP
Indiana University School of Medicine
Evernard Davis III
Current Dialysis Patient, Retired Energy Consultant:
Causes for syncope are multifaceted. Hormonal etiology, specifically hypothyroidism, is associated with cardiac arrhythmias [1]. Sinus bradycardia, low voltage, nonspecific T-wave changes and dissociative atrioventricular (AV) abnormalities are some of descriptive electrocardiographic features [2]. In the majority of well know clinical presentations complete AV block requires the insertion of a permanent pacemaker. However hypothyroidism related bradycardia and consequential symptomatic AV blocks could be reversible with timely and proper management.
We report a case of severe hypothyroidism resulting in insertion of transient pacemaker with favorable clinical course and fully reversible complete AV block after accordant pharmacological hormonal substitution.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Hypokalemia in Emergency Medicine
1. Hypokalemia in Emergency Medicine http://emedicine.medscape.com/article/767448-overview
Author: David Garth, MD; Chief Editor: Erik D Schraga, MD more...
Updated: Apr 2, 2010
Background
Potassium is one of the body's major ions. Nearly 98% of the body's potassium is intracellular. The ratio of intracellular
to extracellular potassium is important in determining the cellular membrane potential. Small changes in the
extracellular potassium level can have profound effects on the function of the cardiovascular and neuromuscular
systems.[1, 2, 3]
The kidney determines potassium homeostasis, and excess potassium is excreted in the urine.
The reference range for serum potassium level is 3.5-5 mEq/L, with total body potassium stores of approximately 50
mEq/kg (ie, approximately 3500 mEq in a 70-kg person).
Hypokalemia is defined as a potassium level less than 3.5 mEq/L.
Moderate hypokalemia is a serum level of 2.5-3 mEq/L.
Severe hypokalemia is defined as a level less than 2.5 mEq/L.
Pathophysiology
Hypokalemia may result from conditions as varied as renal or GI losses, inadequate diet, transcellular shift (movement
of potassium from serum into cells), and medications.
Epidemiology
Frequency
United States
As many as 20% of hospitalized patients are hypokalemic; however, hypokalemia is clinically significant in only about
4-5% of these patients. Severe hypokalemia is relatively uncommon.
Up to 14% of outpatients who undergo laboratory testing are found to be mildly hypokalemic.
Approximately 80% of patients who are receiving diuretics become hypokalemic.
Sex
Incidence is equal in males and females.
Contributor Information and Disclosures
Author
David Garth, MD Attending Physician, Department of Emergency Medicine, Mary Washington Hospital
David Garth, MD is a member of the following medical societies: American Academy of Emergency Medicine and
American College of Emergency Physicians
Disclosure: Nothing to disclose.
1 of 3 9/3/2011 8:20 AM
2. Hypokalemia in Emergency Medicine http://emedicine.medscape.com/article/767448-overview
Specialty Editor Board
Robin R Hemphill, MD, MPH Associate Professor, Director, Quality and Safety, Department of Emergency
Medicine, Emory University School of Medicine
Robin R Hemphill, MD, MPH is a member of the following medical societies: American College of Emergency
Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College
of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: eMedicine Salary Employment
Howard A Bessen, MD Professor of Medicine, Department of Emergency Medicine, University of California, Los
Angeles, David Geffen School of Medicine; Program Director, Harbor-UCLA Medical Center
Howard A Bessen, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.
John D Halamka, MD, MS Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess
Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending
Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency
Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency
Medicine
Disclosure: Nothing to disclose.
Chief Editor
Erik D Schraga, MD Staff Physician, Department of Emergency Medicine, Mills-Peninsula Emergency Medical
Associates
Disclosure: Nothing to disclose.
References
1. [Guideline] ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005
American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular
Care. Circulation. Dec 13 2005;112(24 Suppl):IV1-203. [Medline]. [Full Text].
2. Latronico N, Shehu I, Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care. Aug
2005;11(4):381-90. [Medline].
3. Ingram TC, Olsson JM. In brief: hypokalemia. Pediatr Rev. Sep 2008;29(9):e50-1. [Medline].
4. Seigel JD, Di Palma JA. Medical treatment of constipation. Clin Colon Rectal Surg. 2005;18(2):76-80.
5. Reactions Weekly. Dextrose: First report of ventricular arrhythmia: case report. Reactions Weekly.
2005;1046:11.
6. Greenfeld D, Mickley D, Quinlan DM, Roloff P. Hypokalemia in outpatients with eating disorders. Am J
Psychiatry. Jan 1995;152(1):60-3. [Medline]. [Full Text].
7. Goldberger ZD. Images in cardiovascular medicine. An electrocardiogram triad in thyrotoxic hypokalemic
periodic paralysis. Circulation. Feb 13 2007;115(6):e179-80. [Medline].
8. [Guideline] Assadi F. Diagnosis of hypokalemia: a problem-solving approach to clinical cases. Iran J Kidney
Dis. Jul 2008;2(3):115-22. [Medline].
9. Becker AE, Grinspoon SK, Klibanski A, Herzog DB. Eating disorders. N Engl J Med. Apr 8
1999;340(14):1092-8. [Medline].
2 of 3 9/3/2011 8:20 AM
3. Hypokalemia in Emergency Medicine http://emedicine.medscape.com/article/767448-overview
10. Cohn JN, Kowey PR, Whelton PK, Prisant LM. New guidelines for potassium replacement in clinical practice:
a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med. Sep 11
2000;160(16):2429-36. [Medline].
11. Dominiczak AF, Semple PF, Fraser R, Lever AF, Wallace AM. Hypokalaemia in alcoholics. Scott Med J. Aug
1989;34(4):489-94. [Medline].
12. Gennari FJ. Hypokalemia. N Engl J Med. Aug 13 1998;339(7):451-8. [Medline].
13. Halperin ML, Kamel KS. Potassium. Lancet. Jul 11 1998;352(9122):135-40. [Medline].
14. Howes LG. Which drugs affect potassium?. Drug Saf. Apr 1995;12(4):240-4. [Medline].
15. Kleinfeld M, Borra S, Gavani S, Corcoran A. Hypokalemia: are elderly females more vulnerable?. J Natl Med
Assoc. Nov 1993;85(11):861-4. [Medline].
16. Küng M. Parenteral adrenergic bronchodilators and potassium. Chest. Mar 1986;89(3):322-3. [Medline].
17. Mandal AK. Hypokalemia and hyperkalemia. Med Clin North Am. May 1997;81(3):611-39. [Medline].
18. Paice BJ, Paterson KR, Onyanga-Omara F, Donnelly T, Gray JM, Lawson DH. Record linkage study of
hypokalaemia in hospitalized patients. Postgrad Med J. Mar 1986;62(725):187-91. [Medline].
19. Singhal PC, Venkatesan J, Gibbons N, Gibbons J. Prevalence and predictors of rhabdomyolysis in patients
with hypokalemia. N Engl J Med. Nov 22 1990;323(21):1488. [Medline].
20. Walters EG, Barnes IC. A survey of hypokalaemia in patients of general practitioners. Br J Clin Pract. May
1988;42(5):192-5. [Medline].
21. Zull DN. Disorders of potassium metabolism. Emerg Med Clin North Am. Nov 1989;7(4):771-94. [Medline].
3 of 3 9/3/2011 8:20 AM